Literature DB >> 15948153

Differential effects of acute and subchronic administration on phencyclidine-induced neurodegeneration in the perinatal rat.

Cheng Z Wang1, Kenneth M Johnson.   

Abstract

Acute and subchronic administration of N-methyl-D-aspartate antagonists to rats in the early postnatal period has been reported to produce widespread and selectively cortical neurotoxicity, respectively. To resolve this apparent discrepancy, we sought to clarify these data by determining the dose and temporal and regional characteristics of acute and subchronic phencyclidine (PCP)-induced neurotoxicity. Measurement of degenerating neurons with the cupric silver technique following a single dose of PCP on postnatal day (PN) 7 revealed that neurodegeneration increased in all areas measured (frontal, parietal and cingulate cortices, striatum, hippocampus, subiculum, and thalamus) within 9 hr. Silver staining peaked at 9-16 hr and was then not detectable or was greatly reduced after 24 hr depending on the specific region. Dose-response analysis at 9 hr showed that the lowest effective dose was 1, 3, and 10 mg/kg for the frontal cortex, hippocampus, and striatum, respectively. However, repeated PCP administration (10 mg/kg) on PN 7, 9, and 11 elicited an increase in silver staining only in the frontal cortex. To determine whether the loss of effect in the striatum and hippocampus was due to a "tolerance" mechanism or to a developmental phenomenon, we compared the effects of PCP given on PN 7, 9, or 11 with those of two doses given on PN 7 and 9 or three doses administered on PN 7, 9, and 11. Analysis of these experiments shows that both developmental factors and unknown mechanisms of tolerance underlie the apparent selective cortical neurotoxicity observed following subchronic PCP administration in perinatal rat pups.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15948153     DOI: 10.1002/jnr.20559

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  14 in total

Review 1.  Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.

Authors:  Jeffrey A Lieberman; Frank P Bymaster; Herbert Y Meltzer; Ariel Y Deutch; Gary E Duncan; Christine E Marx; June R Aprille; Donard S Dwyer; Xin-Min Li; Sahebarao P Mahadik; Ronald S Duman; Joseph H Porter; Josephine S Modica-Napolitano; Samuel S Newton; John G Csernansky
Journal:  Pharmacol Rev       Date:  2008-09       Impact factor: 25.468

2.  Brain-derived neurotrophic factor prevents phencyclidine-induced apoptosis in developing brain by parallel activation of both the ERK and PI-3K/Akt pathways.

Authors:  Yan Xia; Cheng Z Wang; Jie Liu; Noelle C Anastasio; Kenneth M Johnson
Journal:  Neuropharmacology       Date:  2009-11-01       Impact factor: 5.250

Review 3.  Animal models of schizophrenia.

Authors:  C A Jones; D J G Watson; K C F Fone
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

4.  Negative modulation of GABAA α5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats.

Authors:  John P Redrobe; Lisbeth Elster; Kristen Frederiksen; Christoffer Bundgaard; Inge E M de Jong; Garrick P Smith; Anne Techau Bruun; Peter H Larsen; Michael Didriksen
Journal:  Psychopharmacology (Berl)       Date:  2011-11-29       Impact factor: 4.530

5.  Neonatal PCP is more potent than ketamine at modifying preweaning behaviors of Sprague-Dawley rats.

Authors:  Sherin Y Boctor; Cheng Wang; Sherry A Ferguson
Journal:  Toxicol Sci       Date:  2008-07-30       Impact factor: 4.849

6.  Behavioral consequences of NMDA antagonist-induced neuroapoptosis in the infant mouse brain.

Authors:  Carla M Yuede; David F Wozniak; Catherine E Creeley; George T Taylor; John W Olney; Nuri B Farber
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

7.  A combined bioinformatics and chemoinformatics approach for developing asymmetric bivalent AMPA receptor positive allosteric modulators as neuroprotective agents.

Authors:  Haijun Chen; Cheng Z Wang; Chunyong Ding; Christopher Wild; Bryan Copits; Geoffrey T Swanson; Kenneth M Johnson; Jia Zhou
Journal:  ChemMedChem       Date:  2012-12-20       Impact factor: 3.466

8.  Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia--sub-chronic and early postnatal PCP treatment in attentional set-shifting.

Authors:  Brian Villumsen Broberg; Birte Yding Glenthøj; Rebecca Dias; Dorrit Bjerg Larsen; Christina Kurre Olsen
Journal:  Psychopharmacology (Berl)       Date:  2009-04-24       Impact factor: 4.530

9.  Differential role of N-methyl-D-aspartate receptor subunits 2A and 2B in mediating phencyclidine-induced perinatal neuronal apoptosis and behavioral deficits.

Authors:  N C Anastasio; Y Xia; Z R O'Connor; K M Johnson
Journal:  Neuroscience       Date:  2009-08-03       Impact factor: 3.590

10.  Atypical anti-schizophrenic drugs prevent changes in cortical N-methyl-D-aspartate receptors and behavior following sub-chronic phencyclidine administration in developing rat pups.

Authors:  Noelle C Anastasio; Kenneth M Johnson
Journal:  Pharmacol Biochem Behav       Date:  2008-10       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.